104 related articles for article (PubMed ID: 11709058)
1. Cytotoxic signalling by inhibitors of DNA topoisomerase II.
Beck WT; Mo YY; Bhat UG
Biochem Soc Trans; 2001 Nov; 29(Pt 6):702-3. PubMed ID: 11709058
[TBL] [Abstract][Full Text] [Related]
2. DNA damage signals induction of fas ligand in tumor cells.
Mo YY; Beck WT
Mol Pharmacol; 1999 Feb; 55(2):216-22. PubMed ID: 9927611
[TBL] [Abstract][Full Text] [Related]
3. Merbarone, a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE/CED-3-like protease.
Khélifa T; Beck WT
Mol Pharmacol; 1999 Mar; 55(3):548-56. PubMed ID: 10051540
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by dexrazoxane (ICRF-187) through caspases in the absence of c-jun expression and c-Jun NH2-terminal kinase 1 (JNK1) activation in VM-26-resistant CEM cells.
Khélifa T; Beck WT
Biochem Pharmacol; 1999 Oct; 58(8):1247-57. PubMed ID: 10487526
[TBL] [Abstract][Full Text] [Related]
5. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes.
Meng LH; Zhang JS; Ding J
Biochem Pharmacol; 2001 Sep; 62(6):733-41. PubMed ID: 11551518
[TBL] [Abstract][Full Text] [Related]
6. Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.
Kusumoto H; Rodgers QE; Boege F; Raimondi SC; Beck WT
Cancer Res; 1996 Jun; 56(11):2573-83. PubMed ID: 8653700
[TBL] [Abstract][Full Text] [Related]
7. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.
Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB
Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786
[TBL] [Abstract][Full Text] [Related]
8. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
[TBL] [Abstract][Full Text] [Related]
9. Tirapazamine: a hypoxia-activated topoisomerase II poison.
Peters KB; Brown JM
Cancer Res; 2002 Sep; 62(18):5248-53. PubMed ID: 12234992
[TBL] [Abstract][Full Text] [Related]
10. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine kinase Lyn mediates apoptosis induced by topoisomerase II inhibitors in DT40 cells.
Maruo A; Oishi I; Sada K; Nomi M; Kurosaki T; Minami Y; Yamamura H
Int Immunol; 1999 Sep; 11(9):1371-80. PubMed ID: 10464158
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
13. E1A specifically enhances sensitivity to topoisomerase IIalpha targeting anticancer drug by up-regulating the promoter activity.
Zhou Z; Guan H; Kleinerman ES
Mol Cancer Res; 2005 May; 3(5):271-5. PubMed ID: 15886298
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction between human topoisomerase IIalpha and retinoblastoma protein.
Bhat UG; Raychaudhuri P; Beck WT
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7859-64. PubMed ID: 10393912
[TBL] [Abstract][Full Text] [Related]
15. XK469, a topo IIbeta inhibitor, induces apoptosis in Waldenstrom's macroglobulinemia through multiple pathways.
Mensah-Osman E; Al-Katib A; Dandashi M; Mohammad R
Int J Oncol; 2003 Dec; 23(6):1637-44. PubMed ID: 14612935
[TBL] [Abstract][Full Text] [Related]
16. Formation and longevity of idarubicin-induced DNA topoisomerase II cleavable complexes in K562 human leukaemia cells.
Willmore E; Errington F; Tilby MJ; Austin CA
Biochem Pharmacol; 2002 May; 63(10):1807-15. PubMed ID: 12034365
[TBL] [Abstract][Full Text] [Related]
17. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression.
Faris M; Kokot N; Latinis K; Kasibhatla S; Green DR; Koretzky GA; Nel A
J Immunol; 1998 Jan; 160(1):134-44. PubMed ID: 9551965
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis by deregulated expression of DNA topoisomerase IIalpha.
McPherson JP; Goldenberg GJ
Cancer Res; 1998 Oct; 58(20):4519-24. PubMed ID: 9788593
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular responses to topoisomerase I poisons. Exploiting synergy for improved radiotherapy.
Miyamoto S; Huang TT; Wuerzberger-Davis S; Bornmann WG; Pink JJ; Tagliarino C; Kinsella TJ; Boothman DA
Ann N Y Acad Sci; 2000; 922():274-92. PubMed ID: 11193903
[TBL] [Abstract][Full Text] [Related]
20. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).
Peebles KA; Baker RK; Kurz EU; Schneider BJ; Kroll DJ
Biochem Pharmacol; 2001 Oct; 62(8):1059-70. PubMed ID: 11597574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
